Evidence map›Paper›PMID 33991459›Full record

ArticleAnnals of clinical and translational neurology2021

No strong HLA association with MOG antibody disease in the UK population.

Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, Anu Jacob, Saif Huda, Maria Isabel Leite, Calliope A Dendrou, Jacqueline Palace

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Ten Years ofNeurology(R) neuroimmunology & neuroinflammation · 2025
    Article
  6. Induction of immune tolerance in NMOSD and MOGAD.Therapeutic advances in neurological disorders · 2025
    Review
  7. Review
  8. MOG CNS Autoimmunity and MOGAD.Neurology(R) neuroimmunology & neuroinflammation · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Melissa Grant-PetersNuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Giordani Rodrigues Dos PassosDepartment of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
Hing-Yuen YeungNuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Anu JacobWalton Centre, NHS Foundation Trust, Liverpool, UK.
Saif HudaWalton Centre, NHS Foundation Trust, Liverpool, UK.
Maria Isabel LeiteDepartment of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
Calliope A DendrouNuffield Department of Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID 0000-0003-1179-4021
Jacqueline PalaceDepartment of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
Centre for Human Genetics · GBJohn Radcliffe Hospital · GBUniversity of Liverpool · GB

Funding

Wellcome TrustWellcome Trust 204290/Z/16/Z
6 · The paper itself

Abstract

Improvements in assays for detecting serum antibodies against myelin oligodendrocyte glycoprotein (MOG) have led to the appreciation of MOG-antibody-associated disease (MOGAD) as a novel disorder. However, much remains unknown about its etiology. We performed human leukocyte antigen (HLA) analysis in 82 MOGAD patients of European ancestry in the UK population. No HLA class II associations were observed, thus questioning the mechanism of anti-MOG antibody generation. A weak protective association of HLA-C*03:04 was observed (OR = 0.26, 95% CI = 0.10-0.71, p

Indexed as

AdultAgedAutoantibodiesBiomarkersCohort StudiesFemaleGenetic Association StudiesHLA AntigensHumansMaleMiddle AgedMyelin-Oligodendrocyte GlycoproteinNeuromyelitis OpticaUnited KingdomYoung AdultAutoantibodiesBiomarkersHLA AntigensMyelin-Oligodendrocyte Glycoprotein

Identifiers

PMID33991459
PMCPMC8283171
OpenAlexW3162394508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.